Theriva Biologics Announces Pricing of $2.5 Million Public Offering
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s[...]
09/26/2024 | Press release | Distributed by Public on 09/26/2024 17:31
Please select the service you want to use:
Smartlinks | Kalina Power Limited | News | Crime and Judiciary | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Financial Services | Investment Services | Securities Issuers | Renewable Energy Equipment and Services Companies | Frankfurt Stock Exchange | Australian Securities Exchange (ASX) | Stuttgart Stock Exchange | Chi-X Australia
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact